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A Bleak Outlook
or Tremendous Potential?*
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In this issue of the Journal, Folsom et al. (1) investigate how
7 recently proposed metrics of cardiovascular health from
the American Heart Association (AHA), including 3 tra-
ditional physiologic risk factors and 4 common health
behaviors, are distributed in a large cohort study of U.S.
adults and, importantly, how these metrics relate to future
risk of cardiovascular disease (CVD) events. In setting their
Strategic Impact Goals for 2020, the AHA charted a new
direction by focusing not only on preventing cardiovascular
deaths, but also on improving cardiovascular health (2).
See page 1690
Setting and evaluating progress toward these goals required
a clear and measurable definition of cardiovascular health,
which was ultimately characterized as ideal levels of 3
physiologic risk factors including normal blood pressure,
total cholesterol, and fasting glucose, and 4 health behaviors
including nonsmoking, adequate physical activity, normal
body mass index, and healthy dietary quality (2). The
implications of this shift in focus from simply preventing
disease to promoting health should not be underempha-
sized. This new goal represents a relatively radical departure
from viewing changes in these physiologic risk factors and
especially these health behaviors as simply means to an end,
to promoting healthier levels of these factors and behaviors
as important ends unto themselves.
This vision was at least partly inspired by national trends
demonstrating reductions in age-adjusted rates of CVD
mortality but simultaneous and disturbing trends of un-
changed or increasing prevalence of poor lifestyle risk
factors, including physical inactivity, suboptimal dietary
*Editorials published in the Journal of the American College of Cardiology reflect the
views of the authors and do not necessarily represent the views of JACC or the
American College of Cardiology.
From the Division of Cardiovascular Medicine and Channing Laboratory, Brigham
and Women’s Hospital and Harvard Medical School, Boston, Massachusetts; and the
Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston,
Massachusetts. The author has reported that he has no relationships to disclose.quality, and obesity; increasing associated chronic diseases
such as type 2 diabetes; and dramatic increases in healthcare
use and costs (3). The recent national decreases in CVD
mortality are multifactorial, resulting from changes includ-
ing reductions in smoking and exposure to second-hand
smoke, increased awareness of symptoms and improved
paramedic/rapid-response systems, advances in emergency
department and in-hospital therapies, and population-wide
reductions in blood pressure and cholesterol levels (4,5).
However, concomitantly, rates of nonfatal CVD events
appear relatively flat, due perhaps to a combination of more
sensitive detection methods as well as improved post-event
survival that re-allocates deaths to nonfatal events (render-
ing mortality decreases an overestimate of reductions in
total CVD). More importantly, the use and costs (and
unintended side effects) of procedures and medications are
rising; hospitalizations for downstream complications such
as heart failure are increasing; the incidence and costs of
diabetes are growing; and skyrocketing healthcare expenses
threaten the solvency of the economy and federal govern-
ment (3,6–8). In parallel, in the past several decades, the
majority of Americans have remained fully sedentary or
physically underactive; our diet has become increasingly
dominated by processed foods high in starches, sugars, and
salt, with very low consumption of healthy foods such as
fruits, vegetables, whole grains, nuts, fish, dairy, and vege-
table oils; and the proportions of children and adults who
are overweight or obese have more than doubled (3).
Thus, we are preventing deaths by means of relatively
costly and inefficient disease treatment systems and down-
stream multidrug- and procedure-based prevention ap-
proaches, while witnessing population shifts in fundamental
health behaviors that both undermine these efforts and
substantially increase healthcare use, costs, and lost produc-
tivity (9–11). If trends continue, the burdens of adverse
health behaviors could reverse mortality gains achieved in
recent decades or at best render their maintenance through
disease treatments so costly that other spending priorities
suffer immensely. These tragedies are being played out not
only on the U.S. stage, but on a global scale across nearly all
countries of the world (12).
Folsom et al. (1) provide key evidence of the relevance
and importance of the AHA’s metrics of cardiovascular
health. Strengths include the significance and timeliness of
the research question, the rigorous assessments of both
exposures and outcomes in a prospective cohort design, and
the appropriate methodologic analyses and presentation of
findings. They found that alarmingly few adults in their
cohort achieved ideal cardiovascular health for all 7 metrics,
or for even most of the metrics, consistent with national
data (13). They further demonstrated a powerful graded
relationship between an individual’s number of ideal health
metrics and their risk of future CVD events. For example,
individuals having 0 metrics of ideal cardiovascular health
had a nearly 10-fold higher risk than individuals having 6
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health experienced no CVD events through nearly 20 years
of follow-up.
These data suggest that the majority of cardiovascular
events are preventable, or at least can be delayed until much
later in life, by achieving a handful of quite basic parameters
of cardiovascular health. Previous research has demon-
strated that more optimal levels of sets of biological risk
factors (14) or health behaviors (15) are associated with a
markedly lower risk of future CVD. The findings by Folsom
et al. (1) extend these previous findings by evaluating a
simple set of both physiologic factors and health behaviors
simultaneously, all readily measurable, that were prospec-
tively defined in separate work. This avoids the limitation of
potentially circular reasoning, wherein behavioral risk fac-
tors are identified and defined and tested for relationships
with disease in the same cohort, thereby providing indepen-
dent quantification of the relationships of these risk metrics
with CVD risk. These results provide strong support for use
of the AHA metrics, the distributions of which can be
readily characterized using nationally representative data
from the ongoing National Health and Nutrition Exami-
nation Survey (16), as a powerful tool for quantifying and
monitoring the cardiovascular health of the U.S. population.
These findings also provide clear evidence of the inde-
pendent relevance of both physiologic factors and health
behaviors for cardiovascular risk. Whether or not an indi-
vidual had healthy behaviors, biological risk factors such as
blood pressure, cholesterol, and glucose strongly predicted
future risk of CVD. These results reinforce the currently
accepted emphasis on screening and treating of generally all
individuals for these physiologic risk factors, regardless of
one’s underlying lifestyle. Similarly, and just as importantly,
whether or not an individual had healthy levels of physio-
logic risk factors, health behaviors strongly predicted future
risk of CVD. For example, even among individuals having
untreated blood pressure 120/80 mm Hg, untreated total
cholesterol 200 mg/dl, and untreated fasting glucose
100 mg/dl, the presence or absence of optimal diet
quality, physical activity, adiposity, and smoking habits
remained strongly predictive of a graded differential in CVD
risk. Thus, these behaviors should not be viewed only as
tools to improve selected physiologic risk factors, but as
major independent risk factors onto themselves that require
screening and treatment in generally all individuals (17),
regardless of one’s underlying blood pressure, cholesterol, or
glucose. These findings are consistent with the wide array of
biological pathways influenced by these health behaviors,
including blood pressure, lipid and lipoprotein levels,
glucose-insulin homeostasis, vascular and cardiac function,
thrombosis and coagulation, systemic inflammation, and
arrhythmic risk (17). Each of these physiologic risks and
health behaviors is measured with error in large prospective
studies due to biological variability, imperfect measurement
tools and participant recall, and changes in levels over time.
The influence of such measurement error, particularly dueto temporal changes from baseline, is likely quite large
during 20 years follow-up. Consequently, the true effects of
both these physiologic risk factors and health behaviors on
CVD risk are likely substantially underestimated in this
analysis. Such underestimation would be largest for health
behaviors that are generally measured with greater error
than are physiologic risk factors. Thus, the true impact of
having suboptimal levels of these physiologic risks, and
especially health behaviors, is probably even greater than
seen in this study.
Although drug treatment of blood pressure and choles-
terol is effective and necessary for many individuals, non-
pharmacologic approaches can have a tremendous impact
and be more cost-effective or even cost-saving (9,18,19).
Drug treatment of blood glucose is effective for reducing
microvascular complications such as retinopathy and renal
disease, but benefits for CVD are disappointingly small
(20), and lifestyle approaches appear more effective for both
preventing diabetes and its associated CVD risk factors
(21,22). Thus, whereas drug-based efforts to reduce major
physiologic risk factors for CVD are essential, the findings
by Folsom et al. (1), together with results of previous
studies, call attention to the currently largely untapped
opportunities for both improving physiologic risk factors
and preventing CVD events by targeting health behaviors.
There is now a strong evidence-base for effective behavior
change strategies at the individual level (23). This knowl-
edge should be incorporated into medical training and,
perhaps more relevantly, into improvements in healthcare
systems, including efficient electronic approaches for mon-
itoring physical activity, diet quality, adiposity, and smok-
ing, and restructuring of quality and reimbursement guide-
lines to focus more on these health behaviors. Effective
population level strategies have also been identified for
improving diet quality, activity, energy balance (adiposity),
and smoking (24–32). Translation of this knowledge into
real action is needed. In recent decades, multicomponent
policy-level strategies have been implemented in several
nations with substantial, although still incomplete, success
against smoking (25). Concerted multicomponent policy
efforts of similar, or plausibly even greater, magnitude are
needed to improve diet quality, physical activity, and energy
balance in the United States and other nations and to
continue or, for many large developing nations such as
China, actually begin the struggle against smoking.
Meaningful improvements in diet quality, physical activ-
ity, and energy balance as well as further reductions in
smoking will require paradigm shifts in how we investigate
the determinants of these lifestyle risk factors in research
and how we screen for and target these health behaviors in
the healthcare system, communities, schools, workplaces,
and the policy arena (17). From a pessimistic standpoint,
the outlook appears rather bleak, with very few Americans
currently achieving these basic metrics of cardiovascular
health that so strongly influence CVD risk. On the other
hand, the optimist will see the tremendous potential before
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moderate definitions of optimal physical activity, diet qual-
ity, or energy balance (adiposity), providing enormous room
for improvement. Even modest changes in the distributions
of these health behaviors will produce substantial cardiovas-
cular benefits in both individuals and populations.
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